Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Inspire Medical Systems Inc.
EIR
•Inspire Medical Systems Inc.•June 22, 2018

Inspire Medical Systems Inc. – FDA EIR, Jun 22, 2018

Record Details

Inspire Medical Systems Inc., a manufacturer of the Inspire II Upper Airway Stimulation device, underwent an FDA inspection from June 18-22, 2018. The inspection followed Compliance Program 7382.845 for Medical Device Manufacturers and utilized the Quality System Inspection Technique (QSIT). The FDA issued Form FDA-483, highlighting two significant observations and several verbal concerns. The primary violations included a failure to submit Medical Device Reports (MDRs) within the regulatory 30-day timeframe, with numerous instances showing delays of up to 213 days. This issue was partly attributed to insufficient management resources. Additionally, the company failed to adequately document supplier Corrective and Preventive Actions (CAPAs), with several examples lacking proper corrective action plans, implementation evidence, or timely responses, as required by their own procedures, referencing 21 CFR 803.50(a)(1) and 21 CFR 820.100(b). Verbal observations noted during the inspection included the identified resource constraints impacting regulatory filings, and inconsistencies between CAPA risk analyses and the firm's Risk Management Procedure, which failed to clearly define when field corrective actions were necessary. Furthermore, an international recall for a CE-approved product was not reported to the FDA, a regulatory requirement. Discussions also raised concerns about the device's labeling not explicitly listing "stroke symptoms" as a potential adverse event, despite patient reports, which the company categorized as "Neuropraxia." Inspire Medical Systems Inc. acknowledged the issues and committed to addressing the observations, implying required corrective actions to meet regulatory compliance.

Company
Inspire Medical Systems Inc.
Inspection date
June 22, 2018
Product type
devices
Office
Minneapolis District Office
Person
  • Susan M. Matthias (investigator)
View Company Profile

ID · 66f4e043-f1df-495b-837d-7c19b7d60afa

Violation Codes4
21 CFR 820.19821 CFR 820.3021 CFR 803.50(a)(1)21 CFR 820.100(b)

Full citation text and observation details available on the Dashboard.

Other documents for Inspire Medical Systems Inc.
  • 483 - 2024-05-10May 10, 2024
  • EIR - 2021-09-16September 16, 2021
  • 483 - 2018-06-22June 22, 2018
  • EIR - 2015-04-29April 29, 2015

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Inspire Medical Systems Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.